Compare ATHM & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATHM | VCYT |
|---|---|---|
| Founded | 2008 | 2006 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.9B |
| IPO Year | 2013 | 2013 |
| Metric | ATHM | VCYT |
|---|---|---|
| Price | $23.39 | $47.46 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 9 |
| Target Price | $28.00 | ★ $44.44 |
| AVG Volume (30 Days) | 438.2K | ★ 1.2M |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | ★ 10.30% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.73 | 0.38 |
| Revenue | ★ $951,436,680.00 | $495,141,000.00 |
| Revenue This Year | N/A | $16.02 |
| Revenue Next Year | $1.33 | $10.74 |
| P/E Ratio | ★ $13.37 | $125.52 |
| Revenue Growth | N/A | ★ 16.41 |
| 52 Week Low | $22.95 | $22.61 |
| 52 Week High | $32.70 | $50.71 |
| Indicator | ATHM | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 34.85 | 65.13 |
| Support Level | $23.16 | $45.68 |
| Resistance Level | $24.22 | $48.10 |
| Average True Range (ATR) | 0.62 | 2.03 |
| MACD | 0.06 | 0.24 |
| Stochastic Oscillator | 16.30 | 74.23 |
Founded in 2008 as a media content platform, Autohome is the leading online automobile platform in China, ranking first among automotive service platforms in terms of mobile daily active users, according to QuestMobile. Through its two websites, autohome.com.cn and che168.com, Autohome delivers comprehensive, independent and interactive content and tools to automobile consumers as well as a full suite of services to automakers and dealers. According to iResearch, the company was the largest online automotive advertising and lead generation service provider with 30% market share, in terms of media services and lead generation revenue, in China's online auto platform media advertising market.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.